Being a young adult cancer survivor is bittersweet, bringing both unique struggles and unexpected blessings that shape my ...

Dr. Christopher R. Flowers explains that MRD testing varies by cancer type, with results impacting recurrence risk and ...

An expert explained a potential side effect associated with treatment consisting of Itovebi for breast cancer.

Regarding patients with HER2-negative, estrogen receptor (ER)-positive breast cancer, the phase 3 KEYNOTE-756 study is ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of.

The FDA accepted a supplemental biologics license application for Opdivo plus Yervoy as a first-line treatment for some adult ...

A New Drug Application has been accepted seeking accelerated approval for dordaviprone for patients with recurrent H3 ...

In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, ...

My relationship with lymphedema has been more complicated than my relationship with the mastectomy. While I am less stressed ...

Neoadjuvant Opdivo with platinum-doublet chemo had a statistically significant and clinically meaningful improvement versus ...

An expert explains what biliary tract cancers are and the current landscape of treatment as well as future advancements.